Candel Therapeutics, Inc.
CADLFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Candel Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Source: Candel Therapeutics, Inc. — 10-K filed Mar 28, 2024
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 24, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Vestal Point Capital, LP | 2026-03-31 | 1,125,000 | $5.51M | SEC filing |
| AlphaCentric Advisors LLC | 2026-03-31 | 36,313 | $178K | SEC filing |
| DEUTSCHE BANK AG\ | 2026-03-31 | 33,300 | $163K | SEC filing |
| China Universal Asset Management Co., Ltd. | 2026-03-31 | 12,998 | $63.7K | SEC filing |
| STATE STREET CORP | 2026-03-31 | 818,558 | $4.01M | SEC filing |
| MIRABELLA FINANCIAL SERVICES LLP | 2026-03-31 | 12,489 | $61.2K | SEC filing |
| Taylor Financial Group, Inc. | 2026-03-31 | 16,600 | $81.3K | SEC filing |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2026-03-31 | 111,716 | $547K | SEC filing |
| US BANCORP \DE\ | 2026-03-31 | 731 | $3.58K | SEC filing |
| Birchview Capital, LP | 2026-03-31 | 60,000 | $294K | SEC filing |
| Essential Partners LLC | 2026-03-31 | 9 | $44 | SEC filing |
| RAYMOND JAMES FINANCIAL INC | 2026-03-31 | 40,000 | $196K | SEC filing |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 2026-03-31 | 2,372 | $11.6K | SEC filing |
| Kynam Capital Management, LP | 2026-03-31 | 200,000 | $980K | SEC filing |
| Janney Montgomery Scott LLC | 2026-03-31 | 30,472 | Not shown | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2026-03-31 | 1,035,435 | $5.07M | SEC filing |
| Hudson Bay Capital Management LP | 2026-03-31 | 59,210 | $290K | SEC filing |
| Saturn V Capital Management LP | 2026-03-31 | 2,896,588 | $14.2M | SEC filing |
| Lido Advisors, LLC | 2026-03-31 | 60,257 | $295K | SEC filing |
| COMMONWEALTH EQUITY SERVICES, LLC | 2026-03-31 | 95,395 | $467K | SEC filing |
- Each value is checked against Candel Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Candel Therapeutics, Inc.'s share price.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- Sunbelt Securities, Inc.: 16 shares reported 2025-12-31; 16 shares reported 2026-03-31.
- CITADEL ADVISORS LLC: 226,356 shares reported 2025-12-31; 72,666 shares reported 2026-03-31.
- Boreal Capital Management LLC: 16,000 shares reported 2025-12-31; 16,000 shares reported 2026-03-31.
- Krilogy Financial LLC: 24,000 shares reported 2025-12-31; 30,065 shares reported 2026-03-31.
- Caitong International Asset Management Co., Ltd: 58 shares reported 2025-12-31; 169 shares reported 2026-03-31.
- SUSQUEHANNA INTERNATIONAL GROUP, LLP: 137,408 shares reported 2025-12-31; 112,973 shares reported 2026-03-31.
- GAMMA Investing LLC: 295 shares reported 2025-12-31; 249 shares reported 2026-03-31.
- BRIDGEWAY CAPITAL MANAGEMENT, LLC: 55,100 shares reported 2025-12-31; 75,100 shares reported 2026-03-31.
- Lido Advisors, LLC: 60,201 shares reported 2025-12-31; 60,257 shares reported 2026-03-31.
102 filers have only one report here.
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-02-23 | Manning Paul B · Director | Common Stock | P — Open market or private purchase | +550,458 | 5.45 | SEC filing |
| 2025-07-28 | Nichols William Garrett · Chief Medical Officer | Common Stock | S — Open market or private sale | −937 | 6.98 | SEC filing |
| 2025-06-30 | Nichols William Garrett · Chief Medical Officer | Common Stock | S — Open market or private sale | −781 | 5.04 | SEC filing |
| 2025-03-19 | Tak Paul Peter · Chief Executive Officer | Common Stock | S — Open market or private sale | −400 | 9.00 | SEC filing |
| 2025-03-18 | Tak Paul Peter · Chief Executive Officer | Common Stock | S — Open market or private sale | −25,772 | 8.77 | SEC filing |
| 2025-03-18 | Barone Francesca · Chief Scientific Officer | Common Stock | S — Open market or private sale | −32,146 | 8.76 | SEC filing |
| 2025-03-18 | Nichols William Garrett · Chief Medical Officer | Common Stock | S — Open market or private sale | −45,316 | 8.76 | SEC filing |
| 2025-03-17 | Schoch Charles · See Remarks | Common Stock | S — Open market or private sale | −5,000 | 8.83 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-23 | PAPA JOSEPH C · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +32,000 | SEC filing |
| 2026-06-23 | Nabel Gary J. · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +32,000 | SEC filing |
| 2026-06-23 | Loggia Nicoletta · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +32,000 | SEC filing |
| 2026-06-23 | Nguyen Diem · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +32,000 | SEC filing |
| 2026-06-23 | Martell Christopher · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +32,000 | SEC filing |
| 2026-06-23 | Manning Paul B · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +32,000 | SEC filing |
| 2026-06-23 | Benz Edward J. JR · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +32,000 | SEC filing |
| 2026-06-23 | Radhakrishnan Maha · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +32,000 | SEC filing |
Showing 8 of 28 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2025-02-21 | Aguilar Laura K. · 10% owner | CADL | D — Disposition to the issuer | −10,583 | SEC filing |
| 2025-02-21 | Aguilar Laura K. · 10% owner | CADL | D — Disposition to the issuer | −10,582 | SEC filing |
| 2025-02-10 | Aguilar Laura K. · 10% owner | CADL | D — Disposition to the issuer | −31,335 | SEC filing |
| 2024-12-27 | Aguilar Laura K. · 10% owner | CADL | D — Disposition to the issuer | −50,000 | SEC filing |
| 2024-12-27 | Aguilar Laura K. · 10% owner | CADL | D — Disposition to the issuer | −50,000 | SEC filing |
| 2024-12-26 | Aguilar Laura K. · 10% owner | CADL | D — Disposition to the issuer | −50,000 | SEC filing |
| 2024-12-26 | Aguilar Laura K. · 10% owner | CADL | D — Disposition to the issuer | −50,000 | SEC filing |
| 2024-12-24 | Aguilar Laura K. · 10% owner | CADL | D — Disposition to the issuer | +50,000 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.